Global Protein A Resins Industry is Projected to Reach a Staggering US$ 1,477.01 Million by 2033, driven by the fervor for Monoclonal Antibodies, as per Future Market Insights, Inc.
The US dominates North America's protein A resin market, driven by biopharma's focus on biosimilars & enhanced quality control systems.
NEWARK, Del, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The protein A resins industry is projected to reach *US$ 677.84 million* in 2023. According to a recent analysis by Future Market Insights, the market would likely reach *US$ 1,477.01 million* by 2033. From 2023 to 2033, the market is projected to grow at a *CAGR of 8.1%*.Protein A resins are used in the creation of monoclonal antibodies at a remarkable rate. Demand for monoclonal antibodies has skyrocketed in therapeutic fields like cancer, autoimmune, neurological, and inflammatory illnesses.
Naturally, the development and research of therapeutic antibodies is where the attention of top pharmaceutical corporations is focused. This will advance the medical industry as a whole. The investigation of monoclonal antibodies, the expedited speed of drug development assumed by the biopharmaceutical and biotechnology industries, and increased investment in synthetic biology are some prevalent reasons driving the industry ahead.
*Request A Sample Copy of This Research Report!* https://www.futuremarketinsights.com/reports/sample/rep-gb-1720
The biopharma industries' rising demand for protein-engineered products utilized for therapeutics and vaccine development is expected to fuel market growth. Additionally, elevated demand for pre-packed disposable columns positively impacts the market. Government funding for new research is likely to be high in developed countries such as the United States. This is additionally underpinned by the superior quality of infrastructure the country holds. Furthermore, the pharmaceutical industry is making substantial efforts to advance the medical field and bridge the gap between patients and healthcare facilities by working on therapeutics’ cost-effectiveness.
Progress in Demand for monoclonal antibodies research is expected to uplift the market. It is also expected to unveil noteworthy growth prospects for players showing interest in this market. Manufacturers are also considering shifting their base to emerging territories like China and Japan, which show notable demand for protein A resins market.
*Top Highlights from the FMI’s Analysis of the Protein A Resins Market: *· The United States protein A resins industry is expected to acquire more than 93.5% of the value share of the North American market.
· Within Europe, the United Kingdom protein A resins industry is expected to take 24.1% of the pie in 2033.
· The China market is anticipated to enlarge at a CAGR of 9.8% over the upcoming years.
· High demand for natural protein A resin is expected to yield a large market share in 2023.
· Under the matrix category, the agarose-composed matrix of protein A resins is expected to record 85.8% of the market share in 2023.
· The antibody purification segment is projected to gain 74.8% of the global market.
· The biopharmaceutical manufacturers segment is expected to emerge as the chief end user of the market, gaining as high as 79.2% of the market in 2023.*Newsflash Straight from Leading Market Players:*
· Navigo Proteins GmbH introduced an affinity resin extracted from a baculovirus insect cell known as glycoprotein gp64 in June 2022. For the success of this process, precision capture technology was deployed. This resin can be employed for the vaccine production process.
· Agilent Technologies joined forces with Delaware State University in September 2022 to accelerate the base of minority students who opt for STEM careers.
· Tosoh Biosciences LLC finalized its acquisition of Semba Biosciences in October 2021. The latter is a privately held prominent innovator in multi-column chromatography (MCC) technology and instrumentation. With this recent development, the former company is expected to observe ease in the downstream purification of biologics.
· Navigo and Repligen fulfilled their co-development of a new affinity ligand in September 2021.
· The Life Sciences operations of GE Healthcare were obtained by Danaher Corporation and remarketed as Cytiva in May 2021. *Scope of the Protein A Resins Market Report:*
*Attributes* Details
*Forecast Period* 2023 to 2033
*Historical Data Available for* 2018 to 2022
*Market Analysis* US$ million/ billion for Value
*Key Countries Covered* The United States, Canada, Germany, The United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa
*Key Segments Covered* Product, Matrix, Application, End User, and Region
*Key Companies Profiled* · GE Healthcare
· Thermo Fisher Scientific
· Kaneka Corporation,
· JNC Corporation
· Purolite Life Sciences
· Bio-Rad Laboratories, Inc.
· JSR Corporation (JSR Life Sciences LLC)
· Repligen
· Tosoh Bioscience, Merck Group (Merck Millipore)
· Novasep Holdings SAS, Agilent Technologies, Inc.
· GenScript, Abcam PLC (Expedeon Ltd.)
· Avantor Inc.
· Takara Bio, PerkinElmer, Inc.
· Suzhou Nanomicro Technology Co., Ltd
*Report Coverage* Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
*Act Now to Explore In-Depth Market Analysis: Get an Exclusive Discount Now to Access Market Intelligence: *https://www.futuremarketinsights.com/checkout/1720
*Protein A Resins Market by Category:*
*Product:*
· Natural Protein A Resin
· Recombinant Protein A Resin
*Matrix:*
· Agarose-based Matrix
· Glass or Silica-based Matrix
· Organic Polymer-based Matrix*Application:*
· Immunoprecipitation
· Antibody Purification
*End User:*
· Biopharmaceutical Manufacturers
· Clinical Research Laboratories
· Academic Institutes*Region:*
· North America
· Latin America
· Europe
· East Asia
· South Asia
· Oceania
· The Middle East and Africa (MEA)*Authored by:*
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
*Explore FMI’s related ongoing Coverage on **Healthcare Market Insights** Domain:*
The global diagnostic exosome biomarkers market is anticipated to reach US$ 196.8 million by 2023. Diagnostic exosome biomarkers sales are anticipated to expand at a significant CAGR of 16.3% between 2023 and 2033. By 2033, the diagnostic exosome biomarkers market is expected to be worth US$ 888.5 million.
The global cosmetology market was valued at US$ 108.33 billion. In the current year, 2023, the net worth of total cosmetology procedures could reach a valuation of US$ 118.93 billion. The global market is anticipated to reach nearly US$ 316.05 billion by 2033, following a CAGR of 10.8% from 2023 to 2033.
The electric acupuncture devices market is anticipated to be valued at US$ 13.9 million in 2023, forecast a CAGR of 7.1% to be valued at US$ 27.5 million from 2023 to 2033. From 2018 to 2022, a CAGR of 7.2% was registered for the electric acupuncture devices market.
Small molecule-drug conjugates Market Overview: According to Future Market Insights (FMI), analysis in a recent market survey estimated that the global small molecule-drug conjugates market is expected to reach US$ 3.65 Billion by 2033 at a CAGR of 17.5%.
Small Molecule Innovator CDMO Market Outlook: The market size is projected to be valued at US$ 48.09 billion in 2023 and is expected to rise to US$ 89.43 billion by 2033. The sales of small molecule innovator CDMO are expected to grow at a significant CAGR of 6.4% during the forecast period.
*About Future Market Insights (FMI) *
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
*Contact Us: *
Nandini Singh Sawlani* *
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
*For Sales Enquiries: *sales@futuremarketinsights.com
*Website:* https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube